Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Mar;53(3):895–903. doi: 10.1172/JCI107630

Metabolic Clearance and Production Rates of Human Thyrotropin

E Chester Ridgway 1,2, Bruce D Weintraub 1,2, Farahe Maloof 1,2
PMCID: PMC333072  PMID: 4812446

Abstract

Metabolic clearance (MCR) and production rates (PR) of human thyrotropin (hTSH) were determined by the constant infusion to equilibrium method 57 times in 55 patients. 16 control patients had a mean hTSH MCR of 50.7 ml/min. The mean hTSH MCR was significantly (P < 0.02) higher in 19 euthyroid men (51.6 ml/min) than in 12 euthyroid women (43.0 ml/min), but this apparent sex difference disappeared when the MCR were corrected for surface area, 25.8 (men) versus 25.2 ml/min per m2 (women). Hypothyroid patients had significantly (P < 0.005) lower hTSH MCR (30.9 ml/min), and hyperthyroid patients had significantly (P < 0.05) higher hTSH MCR (60.9 ml/min) than controls. The hTSH MCR in patients with “decreased thyroid reserve” (40.9 ml/min), hyperfunctioning thyroid nodule (53.8 ml/min), and “empty sella syndrome” (46.6 ml/min) were not significantly different from controls. The mean hTSH PR in controls (104.3 mU/day) was significantly (P < 0.005) different from that in patients with “decreased thyroid reserve” (956 mU/day), hypothyroidism (4,440 mU/day), hyperthyroidism (< 43.9 mU/day) and a hyperfunctioning thyroid nodule (< 38.7 mU/day). In primary hypothyroidism intravenous triiodothyronine therapy (50 μg/day) for 10 days decreased the hTSH PR (from 4,244 to 2,461 mU/day) before changes in the hTSH MCR (from 33.1 to 33.7 mU/day) were observed.

These studies have demonstrated that changes in the serum concentration of hTSH are mainly due to altered pituitary hTSH secretion with only a minor contribution from the change in hTSH MCR.

Full text

PDF
895

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKKE J., LAWRENCE N., ROY S. Disappearance rate of exogenous thyroid-stimulating hormone (TSH) in man. J Clin Endocrinol Metab. 1962 Apr;22:352–363. doi: 10.1210/jcem-22-4-352. [DOI] [PubMed] [Google Scholar]
  2. Beckers C., Machiels J., Soyez C., Cornette C. Metabolic clearance rate and production rate of thyroid-stimulating hormone in man. Horm Metab Res. 1971 Jan;3(1):34–36. doi: 10.1055/s-0028-1095044. [DOI] [PubMed] [Google Scholar]
  3. Coble Y. D., Jr, Kohler P. O., Cargille C. M., Ross G. T. Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women. J Clin Invest. 1969 Feb;48(2):359–363. doi: 10.1172/JCI105992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. D'ANGELO S. A. Disappearance rate of exogenous thyrotrophin from the blood of normal and hypophysectomized rats. Endocrinology. 1951 Mar;48(3):249–256. doi: 10.1210/endo-48-3-249. [DOI] [PubMed] [Google Scholar]
  5. D'ANGELO S. A. The metabolism of thyrotrophic hormone in the rat. Endocrinology. 1955 Jan;56(1):37–45. doi: 10.1210/endo-56-1-37. [DOI] [PubMed] [Google Scholar]
  6. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  7. Hershman J. M., Pittman J. A., Jr Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med. 1971 Apr;74(4):481–490. doi: 10.7326/0003-4819-74-4-481. [DOI] [PubMed] [Google Scholar]
  8. Kohler P. O., Ross G. T., Odell W. D. Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women. J Clin Invest. 1968 Jan;47(1):38–47. doi: 10.1172/JCI105713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mayberry W. E., Gharib H., Bilstad J. M., Sizemore G. W. Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function. Ann Intern Med. 1971 Apr;74(4):471–480. doi: 10.7326/0003-4819-74-4-471. [DOI] [PubMed] [Google Scholar]
  10. Nelson D. H., Sprunt J. G., Mims R. B. Plasma ACTH determinations in 58 patients before or after adrenalectomy for Cushing's syndrome. J Clin Endocrinol Metab. 1966 Jul;26(7):722–728. doi: 10.1210/jcem-26-7-722. [DOI] [PubMed] [Google Scholar]
  11. Odell W. D., Utiger R. D., Wilber J. F., Condliffe P. G. Estimation of the secretion rate of thyrotropin in man. J Clin Invest. 1967 Jun;46(6):953–959. doi: 10.1172/JCI105601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
  13. Patel Y. C., Alford F. P., Burger H. G. The 24-hour plasma thyrotrophin profile. Clin Sci. 1972 Jul;43(1):71–77. doi: 10.1042/cs0430071. [DOI] [PubMed] [Google Scholar]
  14. Patel Y. C., Burger H. G., Hudson B. Radioimmunoassay of serum thyrotropin: sensitivity and specificity. J Clin Endocrinol Metab. 1971 Nov;33(5):768–774. doi: 10.1210/jcem-33-5-768. [DOI] [PubMed] [Google Scholar]
  15. Ridgway E. C., Weintraub B. D., Cevallos J. L., Rack M. C., Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest. 1973 Nov;52(11):2783–2792. doi: 10.1172/JCI107474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vanhaelst L., Van Cauter E., Degaute J. P., Golstein J. Circadian variations of serum thyrotropin levels in man. J Clin Endocrinol Metab. 1972 Sep;35(3):479–482. doi: 10.1210/jcem-35-3-479. [DOI] [PubMed] [Google Scholar]
  17. Webster B. R., Guansing A. R., Paice J. C. Absence of diurnal variation of serum TSH. J Clin Endocrinol Metab. 1972 May;34(5):899–901. doi: 10.1210/jcem-34-5-899. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES